NASDAQ:ALDX

Aldeyra Therapeutics Stock News

Healthcare > Biotechnology

Buy ALDX

*Your capital is at risk

$1.86

+0.220 (+13.41%)

At Close: Jun 03, 2026

Aldeyra Therapeutics, Inc. (ALDX) Faces Scrutiny After Stock Drops 70% On FDA's Reproxalap Complete Response Letter – Hagens Berman

05:00pm, Wednesday, 09'th Apr 2025

SAN FRANCISCO, April 09, 2025 (GLOBE NEWSWIRE) -- On April 3, 2025 investors in Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) saw the price of their shares crash over 70% after the company announced that

ALDX CLASS ALERT: BFA Law Reminds Aldeyra Therapeutics, Inc. Investors of the Ongoing Securities Investigation

03:46pm, Wednesday, 09'th Apr 2025

NEW YORK CITY, NY / ACCESS Newswire / April 9, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) for potential viol

Bronstein, Gewirtz & Grossman, LLC Encourages Aldeyra Therapeutics, Inc. (ALDX) Stockholders to Inquire about Securities Investigation

10:00am, Wednesday, 09'th Apr 2025

NEW YORK CITY, NY / ACCESS Newswire / April 9, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Aldeyra Therapeutics, Inc. ("Aldeyra" or "the Comp

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDX

08:00am, Wednesday, 09'th Apr 2025

NEW YORK, NY / ACCESS Newswire / April 9, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Aldeyra Therapeutics, Inc. ("Aldeyra" or the "Company") (NASDAQ:ALDX). Such investors a

ALDX SECURITIES NOTE: Aldeyra Therapeutics, Inc. Investors with Losses may have been Affected by Securities Violations; Contact BFA Law

03:33pm, Tuesday, 08'th Apr 2025

NEW YORK CITY, NY / ACCESS Newswire / April 8, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) for potential viol

After A CRL Setback, Aldeyra Therapeutics Is A Compelling Speculative Buy

04:51am, Tuesday, 08'th Apr 2025

Aldeyra Therapeutics' stock plummeted 74% due to an FDA Complete Response Letter for reproxalap but presents a favorable risk-reward for speculative investors. Despite past setbacks, ALDX's history of

ALDX SECURITIES UPDATE: Lose Money when Aldeyra Therapeutics, Inc. Stock Plummeted 75%? Contact BFA Law about its Ongoing Securities Investigation

03:20pm, Monday, 07'th Apr 2025

NEW YORK, NY / ACCESS Newswire / April 7, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) for potential violation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Aldeyra Therapeutics, Inc. (ALDX) and Encourages Stockholders to Learn More About the Investigation

10:00am, Monday, 07'th Apr 2025

NEW YORK CITY, NY / ACCESS Newswire / April 7, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Aldeyra Therapeutics, Inc. ("Aldeyra" or "the Comp

ALDX SECURITIES REPORT: Aldeyra Therapeutics, Inc. Securities Investigation Could Allow Investors to Recover Losses; Contact BFA Law (NASDAQ:ALDX)

08:16am, Monday, 07'th Apr 2025

NEW YORK, April 07, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) for potential violations o

Bronstein, Gewirtz & Grossman, LLC Encourages Aldeyra Therapeutics, Inc. (ALDX) Investors to Inquire about Securities Investigation

10:00am, Sunday, 06'th Apr 2025

NEW YORK CITY, NY / ACCESS Newswire / April 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Aldeyra Therapeutics, Inc. ("Aldeyra" or "the Comp

ALDX SECURITIES ALERT: Aldeyra Therapeutics, Inc. Investors are Notified of the Ongoing Securities Investigation; Contact BFA Law (NASDAQ:ALDX)

07:11am, Saturday, 05'th Apr 2025

NEW YORK, April 05, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) for potential violations o

Kirby McInerney LLP Announces Investigation of Possible Claims Against Aldeyra Therapeutics, Inc. (ALDX) on Behalf of Investors

08:00pm, Friday, 04'th Apr 2025

NEW YORK, April 04, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Aldeyra Therapeutics, Inc. (“Aldeyra” or the “Company”) (NASDAQ:ALDX)

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDX

10:00am, Friday, 04'th Apr 2025

NEW YORK CITY, NY / ACCESS Newswire / April 4, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Aldeyra Therapeutics, Inc. ("Aldeyra" or the "Company") (NASDAQ:ALDX). Such invest

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Aldeyra Therapeutics, Inc. (ALDX) And Encourages Investors to Reach Out

10:00am, Friday, 04'th Apr 2025

NEW YORK CITY, NY / ACCESS Newswire / April 4, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Aldeyra Therapeutics, Inc. ("Aldeyra" or "the Comp

ALDX NOTIFICATION: Aldeyra Therapeutics, Inc. is being Investigated for Securities Violations after 75% Stock Drop; Investors with Losses are Notified to Contact BFA Law

07:33am, Friday, 04'th Apr 2025

NEW YORK, NY / ACCESS Newswire / April 4, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) for potential violation

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by